QT
PTGX icon

Quantbot Technologies’s Protagonist Therapeutics PTGX Stock Holding History

Quantbot Technologies’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.9K Buy
+342
New +$35.7K ﹤0.01% 1674
2025
Q4 		– Sell
-3,303
Closed -$219K – 2078
2025
Q3 		$219K Buy
+3,303
New +$188K 0.01% 1262
2023
Q1 		– Sell
-6,700
Closed -$73.1K – 1970
2022
Q4 		$73.1K Buy
6,700
+5,700
+570% +$48.1K 0.01% 1226
2022
Q3 		$8K Sell
1,000
-8,658
-90% -$81.9K ﹤0.01% 1449
2022
Q2 		$76K Buy
+9,658
New +$117K 0.01% 1214
2022
Q1 		– Sell
-13,104
Closed -$448K – 1976
2021
Q4 		$448K Buy
+13,104
New +$414K 0.04% 561
2021
Q2 		– Sell
-954
Closed -$24K – 1784
2021
Q1 		$24K Buy
+954
New +$24.1K ﹤0.01% 1141
2020
Q4 		– Sell
-300
Closed -$5K – 1604
2020
Q3 		$5K Buy
+300
New +$5.63K ﹤0.01% 1190

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Quantbot Technologies's PTGX Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Protagonist Therapeutics (PTGX) in Q2 2026: 342 shares worth $41.9K. The stake represents ﹤0.01% of the portfolio and ranks #1674 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in PTGX as recently as Q3 2025.

Quantbot Technologies first reported a position in PTGX in Q3 2020 and has held it in 8 quarters since. The position peaked at $448K in Q4 2021. 344 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Quantbot Technologies held 342 shares of Protagonist Therapeutics worth $41.9K as of Q2 2026.
  • Protagonist Therapeutics was a new Quantbot Technologies position in Q2 2026.
  • Protagonist Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1674 holding.
  • Quantbot Technologies first reported a position in Protagonist Therapeutics in Q3 2020 and has held it in 8 quarters since.
  • Quantbot Technologies's Protagonist Therapeutics position peaked at $448K in Q4 2021.
  • 344 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.